212 related articles for article (PubMed ID: 30844308)
1. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.
Simoni JM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Tapia K; Graham SM; Ho R; Collier AC
AIDS Patient Care STDS; 2019 Mar; 33(3):104-111. PubMed ID: 30844308
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of Long-Acting Injectable Antiretroviral Therapy Among People with HIV Receiving Care at Three Ryan White Funded Clinics in the United States.
Erguera XA; Koester KA; Diaz Tsuzuki M; Dance KV; Flores R; Kerman J; McNulty MC; Colasanti JA; Collins LF; Montgomery ET; Johnson MO; Sauceda JA; Christopoulos KA
AIDS Behav; 2024 Jul; 28(7):2226-2238. PubMed ID: 38598026
[TBL] [Abstract][Full Text] [Related]
3. "Lighten This Burden of Ours": Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya.
Simoni JM; Beima-Sofie K; Wanje G; Mohamed ZH; Tapia K; McClelland RS; Ho RJY; Collier AC; Graham SM
J Int Assoc Provid AIDS Care; 2021; 20():23259582211000517. PubMed ID: 33685272
[TBL] [Abstract][Full Text] [Related]
4. A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use.
Philbin MM; Parish C; Bergen S; Kerrigan D; Kinnard EN; Reed SE; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Alcaide ML; Metsch LR
AIDS Patient Care STDS; 2021 Jan; 35(1):23-30. PubMed ID: 33400587
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of Long-Acting Injectable Antiretroviral Therapy Among People Living with HIV Who Use Drugs and Service Providers: a Qualitative Analysis in Rhode Island.
Collins AB; Macon EC; Langdon K; Joseph R; Thomas A; Dogon C; Beckwith CG
J Urban Health; 2023 Oct; 100(5):1062-1073. PubMed ID: 37563518
[TBL] [Abstract][Full Text] [Related]
6. High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda.
Kennedy CE; Zhao T; Vo AV; Nakubulwa R; Nabakka P; Jackson J; Rosen JG; Chang LW; Reynolds SJ; Quinn TC; Nakigozi G; Kigozi G; Kagaayi J; Nalugoda F; Ddaaki WG; Grabowski MK; Nakyanjo N
AIDS Patient Care STDS; 2023 Jun; 37(6):316-322. PubMed ID: 37294280
[TBL] [Abstract][Full Text] [Related]
7. Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
Philbin MM; Parish CL; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
J Acquir Immune Defic Syndr; 2020 Jul; 84(3):263-270. PubMed ID: 32530905
[TBL] [Abstract][Full Text] [Related]
8. Long-Acting Injectable ART in Practice: A Mixed Methods Implementation Study Assessing the Feasibility of Using LAI ART in High Risk Populations and At Alternative Low Barrier Care Sites.
Fletcher L; Burrowes S; Sabin LL; McCann N; Khan GK; Ruiz-Mercado G; Johnson S; Kimmel SD; Pierre C; Drainoni ML
AIDS Patient Care STDS; 2024 May; 38(5):221-229. PubMed ID: 38656905
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States.
McCrimmon T; Collins LF; Perez-Brumer A; Bazzi AR; Shaffer VA; Kerrigan D; Alcaide ML; Philbin MM
AIDS Patient Care STDS; 2024 Feb; 38(2):61-69. PubMed ID: 38381949
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences.
Carillon S; Gallardo L; Linard F; Chakvetadze C; Viard JP; Cros A; Molina JM; Slama L
AIDS Care; 2020 May; 32(sup2):155-161. PubMed ID: 32189506
[TBL] [Abstract][Full Text] [Related]
11. A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.
Simoni JM; Tapia K; Lee SJ; Graham SM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Ho R; Collier AC
AIDS Behav; 2020 Apr; 24(4):1226-1236. PubMed ID: 31655915
[TBL] [Abstract][Full Text] [Related]
12. Implementing long-acting injectable antiretroviral treatments in Senegal: issues, challenges and conditions for introducing them. Qualitative study with healthcare providers and patients.
Carillon S; Laborde-Balen G; Diop M; Diop K; Breton G; Ndiaye B; Taverne B
AIDS Care; 2024 May; 36(5):703-709. PubMed ID: 37708454
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.
Fletcher L; Burrowes SAB; Khan GK; Sabin L; Johnson S; Kimmel SD; Ruiz-Mercado G; Pierre C; Drainoni ML
Harm Reduct J; 2023 Jan; 20(1):4. PubMed ID: 36627679
[TBL] [Abstract][Full Text] [Related]
14. Exploring the acceptability of Option B plus among HIV-positive Nigerian women engaged and not engaged in the prevention of mother-to-child transmission of HIV cascade: a qualitative study.
Erekaha SC; Cornelius LJ; Bessaha ML; Ibrahim A; Adeyemo GD; Fadare M; Charurat M; Ezeanolue EE; Sam-Agudu NA
SAHARA J; 2018 Dec; 15(1):128-137. PubMed ID: 30253709
[TBL] [Abstract][Full Text] [Related]
15. LAI-ART Awareness, Willingness, Barriers and Facilitators among Black Sexual Minority Men Living with HIV in the US South.
Campbell CK; Kielhold K; Reynolds HE; Vincent W; Siconolfi DE; Ramos SD; Ogunbajo A; Kegeles SM; Storholm ED
Int J Environ Res Public Health; 2024 May; 21(5):. PubMed ID: 38791816
[TBL] [Abstract][Full Text] [Related]
16. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
[TBL] [Abstract][Full Text] [Related]
17. If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.
Davis A; Sarsembayeva L; Gulyaev V; Primbetova S; Terlikbayeva A; Mergenova G; Remien RH
AIDS Behav; 2019 Dec; 23(12):3294-3305. PubMed ID: 30741397
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of Long-Acting Injectable Antiretroviral Treatment Regimens in a United States Urban Academic Medical Center.
Koren DE; Fedkiv V; Zhao H; Kludjian G; Bettiker RL; Tedaldi E; Samuel R
J Int Assoc Provid AIDS Care; 2020; 19():2325958220981265. PubMed ID: 33327851
[TBL] [Abstract][Full Text] [Related]
19. Key informant views on potential acceptability and feasibility of long-acting antiretroviral treatment for HIV in Kenya.
Kaggiah A; Maina CN; Kinuthia J; Barthold D; Hauber B; Tran J; Simoni JM; Graham SM
BMC Infect Dis; 2024 Apr; 24(1):415. PubMed ID: 38641565
[TBL] [Abstract][Full Text] [Related]
20. Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada.
Gelhorn H; Garris C; Arthurs E; Spinelli F; Cutts K; Chua GN; Collacott H; Lebouché B; Lowman E; Rice H; Heidenreich S
J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
